Comparative Effectiveness and Safety of Denosumab Versus Bisphosphonates in Osteoporosis Management Among Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study

被引：0
|
作者：
Khataniar, H. [1 ]
Desai, A. [2 ]
Kochhar, G. [2 ]
机构：
[1] Allegheny Hlth Network, Dept Med, Pittsburgh, PA USA
[2] Allegheny Hlth Network, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0873
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0699
引用
收藏
页码：i1366 / i1367
页数：2
相关论文
共 50 条
  • [41] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    Singh, Siddharth
    Andersen, Nynne Nyboe
    Andersson, Mikael
    Loftus, Edward V., Jr.
    Jess, Tine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
  • [42] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    Singh, Siddharth
    Andersen, Nynne Nyboe
    Andersson, Mikael
    Loftus, Edward V., Jr.
    Jess, Tine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
  • [43] Chronic kidney disease–related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score–matched cohort study
    C.-T. Chao
    J. Wang
    J.-W. Huang
    D.-C. Chan
    K.-Y. Hung
    K.-L. Chien
    Osteoporosis International, 2020, 31 : 699 - 708
  • [44] Are Appendectomies Beneficial in Patients With Inflammatory Bowel Disease? A US Nationwide Cohort Study
    Basida, Sanket
    Pathiyil, Mythili Menon
    Yousaf, Muhammad Nadeem.
    Ghouri, Yezaz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S734 - S734
  • [45] SAFETY AND EFFECTIVENESS OF GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER COHORT STUDY
    Toita, Nariaki
    Tanaka, Hiroki
    Arai, Katsuhiro
    Shimizu, Hirotaka
    Abukawa, Daiki
    Kobayashi, Toshihisa
    Yoshimura, Naoki
    Tanida, Satoshi
    Hosoi, Eiji
    GASTROENTEROLOGY, 2019, 156 (06) : S667 - S667
  • [46] COMPARATIVE EFFECTIVENESS OF RISANKINUMAB, USTEKINUMAB, AND VEDOLIZUMAB IN PATIENTS WITH FIBROSTENOTIC CROHN'S DISEASE: A PROPENSITY SCORE-MATCHED COHORT STUDY
    Wu, Meng-Che
    Ma, Kevin
    Huang, Pin-Chia
    Chan, Shu-Yen
    Winter, Harland
    GASTROENTEROLOGY, 2024, 166 (05) : S1427 - S1427
  • [47] The Incidence and Prevalence of Inflammatory Bowel Disease Among US Veterans: A National Cohort Study
    Hou, Jason K.
    Kramer, Jennifer R.
    Richardson, Peter
    Mei, Minghua
    El-Serag, Hashem B.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (05) : 1059 - 1064
  • [48] Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study
    Petrov, Jessica C.
    Desai, Aakash A.
    Kochhar, Gursimran S.
    Crosby, Sheena K.
    Kinnucan, Jami A.
    Picco, Michael F.
    Hashash, Jana G.
    Farraye, Francis A.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [49] Clinical effectiveness and safety of ustekinumab in youth with refractory inflammatory bowel disease: A retrospective cohort study
    Alhadab, Abdulhamid
    Almarhoon, Amal
    Alalwan, Amena
    Hammo, Abdelhai
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2025, 31 (02): : 59 - 67
  • [50] COEXISTING INFLAMMATORY BOWEL DISEASE AND BARRETT'S ESOPHAGUS IS ASSOCIATED WITH INCREASED ESOPHAGEAL DYSPLASIA: A PROPENSITY MATCHED COHORT STUDY
    Fasullo, Matthew
    Sreenivasen, Aditya
    Holzwanger, Erik A.
    Lavender, Charles A.
    Patel, Milan
    Shah, Tilak
    Mutha, Pritesh R.
    Trindade, Arvind J.
    Smallfield, George
    GASTROENTEROLOGY, 2021, 160 (06) : S244 - S245
12345